Evidence map›Paper›PMID 32671088›Full record

ArticleFrontiers in nutrition2020

Intestinal Microbiota and Immune Modulation in Zebrafish by Fucoidan From Okinawa Mozuku (

Wakako Ikeda-Ohtsubo, Adrià López Nadal, Edoardo Zaccaria, Masahiko Iha, Haruki Kitazawa, Michiel Kleerebezem, Sylvia Brugman

Open access · goldAbstract read
In one paragraph

Article in Frontiers in nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Effects ofPeerJ · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Dietary Inclusion of Seabuckthorn (Frontiers in physiology · 2022
    Article
  15. Article
  16. Fucoidans and Bowel Health.Marine drugs · 2021
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Wakako Ikeda-OhtsuboCell Biology and Immunology Group, Department of Animal Sciences, Wageningen University and Research, Wageningen, Netherlands.
Adrià López NadalCell Biology and Immunology Group, Department of Animal Sciences, Wageningen University and Research, Wageningen, Netherlands.
Edoardo ZaccariaHost-Microbe Interactomics Group, Department of Animal Sciences, Wageningen University and Research, Wageningen, Netherlands.
Masahiko IhaSouth Product Co., Ltd., Uruma, Japan.
Haruki KitazawaLaboratory of Animal Products Chemistry, Graduate School of Agricultural Science, Tohoku University, Sendai, Japan.
Michiel KleerebezemHost-Microbe Interactomics Group, Department of Animal Sciences, Wageningen University and Research, Wageningen, Netherlands.
Sylvia BrugmanCell Biology and Immunology Group, Department of Animal Sciences, Wageningen University and Research, Wageningen, Netherlands.
Wageningen University & Research · NLTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fucoidan represents fucose-rich sulfated polysaccharides derived from brown seaweeds, which exerts various biological activities applicable for functional foods and therapeutic agents. The objective of the present study was to investigate

Indexed as

fucoidanimmunomodulationmicrobiotaseaweed polysaccharideszebrafish

Identifiers

PMID32671088
PMCPMC7327095
OpenAlexW3033341667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.